Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 370)
Posted On: 12/11/2020 6:02:29 PM
Post# of 36568
Posted By: rvbpk
Re: Paul Jackson #24433
Gotcha.. you are right outstanding after IPO , 265m + .. Like the fact that they are making revenue and profit..

AbCellera Biologics Inc. ABCL, +194.50% said Monday that terms of its initial public offering have been set, which could value the artificial intelligence (AI)-powered drug discovery company at up to $4.52 billion. The Vancouver-based company, which is working with Eli Lilly & Co. LLY, -0.60% on a COVID-19 therapy, said it is offering 23 million shares in the IPO, which is expected to price between $14 and $17 a share, which means the company could raise as much as $391 million. The company expects to have 265.95 million shares outstanding after the IPO. The shares are expected to list on the Nasdaq under the ticker symbol "ABCL." Credit Suisse, Stifel, Berenberg, SVG Leerink and BMO Capital Markets are the underwriters. For the nine months ended Sept. 30, the company reported net income of $1.9 million on revenue of $25.2 million, after a loss of about $570,000 on revenue of $8.4 million in the same period a year ago.













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site